Do low IgG and non-elevated IgM argue against immunoglobulin excess as the cause of thick blood?

At age 77, a report of “thick blood” warrants distinguishing plasma viscosity (proteins) from whole-blood viscosity (cells and hematocrit). The available immunoglobulin pattern weighs against—but does not definitively eliminate—an immunoglobulin-mediated cause.

Clinical evidence

• Elevated monoclonal paraproteins are an established cause of plasma hyperviscosity. IgM is particularly potent because its pentameric structure can markedly raise viscosity at relatively modest elevations.
• Approximate concentrations associated with increased risk are IgM ≥3 g/dL (more commonly 5–6 g/dL), IgA 6–7 g/dL, and IgG often >10 g/dL; protein properties and aggregation modify these relationships.
• Below-range total IgG and non-elevated IgM therefore do not fit the usual pattern of high intact immunoglobulin concentrations causing hyperviscosity. Clinical concern is greater with mucosal bleeding, visual disturbance/retinal hemorrhage, or neurologic symptoms; fatigue or dizziness alone are nonspecific. Symptoms are generally unlikely below serum viscosity of ~4 cP, although thresholds vary.

Mechanisms and diagnostic implications

• Quantitative immunoglobulins cannot exclude a small monoclonal protein, immunoparesis-associated clone, or light-chain-only disorder. SPEP plus serum free-light-chain testing is appropriate initial testing when monoclonal gammopathy is suspected; immunofixation increases detection of small proteins. In one cohort, free light chains were the sole laboratory evidence in 17.0% of newly evaluated patients with a monoclonal protein.
• “Thick blood” may instead reflect erythrocytosis/increased hematocrit, abnormal red-cell rheology, marked leukocytosis, elevated fibrinogen, or cryoglobulin precipitation. Fibrinogen raises plasma viscosity and promotes red-cell aggregation; erythrocytosis raises whole-blood viscosity.

Bottom line

• The low IgG and non-elevated IgM make immunoglobulin excess an unlikely explanation, but do not rule out an occult monoclonal protein or non-immunoglobulin cause. Directed protein studies and, when clinically indicated, direct viscosity and CBC/hematocrit assessment distinguish these mechanisms.